Comments
Shares of Lupin Limited dropped six per cent Thursday after the company received three observations from the US health regulator for its Aurangabad-based manufacturing facility.
The scrip declined 6 per cent to Rs 736.10 on the Bombay Stock Exchange (BSE).
On the National Stock Exchange (NSE), shares tanked 5.84 per cent to Rs 736.40.
The United States Food and Drug Administration (USFDA) carried out the inspection at the plant from May 6 to May 15, Lupin said in a statement Wednesday.
“The inspection at the Aurangabad facility closed with three observations. The company is confident of addressing them satisfactorily,” it added.
Lupin Wednesday posted consolidated profit after tax of Rs 296.37 crore for the fourth quarter of 2018-19 fiscal.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.